公司資料
Vivos Therapeutics 股價、新聞與催化劑
- 股票代碼:
- VVOS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.30 USD (-12.26%)
收盤價
最後更新: 2026年8月17日
9.42M USD
市值
股價為何變動
Following the latest company update, “Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update”, VVOS closed down 12.3% at $0.3012 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
公司概覽
Sleep-Related Breathing Disorder Platform
Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired nighttime breathing.
CARE Oral Appliances
The company's Complete Airway Repositioning and Expansion, or CARE, devices are designed to modify the oral and craniofacial structures associated with airway obstruction. The portfolio includes FDA-cleared appliances for adults across the spectrum of obstructive sleep apnea severity, including severe disease.
Pediatric and Adult Indications
Vivos has expanded its regulatory footprint beyond adult treatment. Its DNA appliance is FDA-cleared for moderate-to-severe obstructive sleep apnea in children ages six through 17, giving the company a platform spanning both pediatric and adult populations.
Integrated Diagnostic and Treatment Services
In addition to device sales, Vivos operates Sleep and Airway Medicine Centers and Sleep Center of Nevada. These businesses provide sleep testing, physician-directed treatment, and related services, creating an integrated model that connects diagnosis with oral-appliance and broader sleep-care delivery.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。